The genome-editing technology can be supercharged by artificial intelligence—and the results are already being felt.

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Today’s mass-produced tomatoes often grow to palm-sized proportions, but their naturally occurring ancestors were far smaller ...

Researchers have used whole-genome CRISPR interference screening to identify the “Achilles Heel” of drug-resistant ...

Crispr Therapeutics, a leader in CRISPR/Cas9 ... in the history of molecular biology”, Crispr have obtained several benefits – some of which are intangible but important – that collectively ...

Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals.

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

CRISPR-Cas9 has long been likened to a kind of genetic scissors, thanks to its ability to snip out any desired section of DNA with elegant precision. But it turns out that CRISPR systems have more ...

CRISPR Therapeutics had its first FDA-approved product in December 2023, a treatment for sickle cell disease called Casgevy. It’s also developing treatments for cancer and cardiovascular disease ...